… This trial demonstrated a 64% reduction in clinical worsening and a 55% reduction in death
on day 28, as well as an 80% reduction in patients with laboratory criteria for cytokine storm …

… In this way, the model presented here explains why there is not, and can never be, a
universal definition of a “cytokine storm”, nor a single set of clinical criteria for diagnosis. Each …

… clinical usefulness of tocilizumab in the treatment of COVID-19-induced CRS. These cases
highlight the need for clinical … Our report further challenges the clinical usefulness of anti-IL-6 …

… is cytokine storm, a hyperinflammatory process of cytokine … Inflammatory cytokines, more
specifically interleukins, are … in serum IL-6 and IL-10 worsens COVID-19 clinical outcomes. …

… of a cytokine storm syndrome before progression to life threatening, multiple organ dysfunction
remains a clinical … The cytokine storm syndrome encompasses familial and secondary …

… that systemic inflammation responses, cytokine storms and dysregulated immune responses
occurred and exerted combined effects on the clinical progression in COVID-19, which …

… cytokine storms, the use of immune-boosting systems may be suggested as another way to
control cytokine storm. … of a randomized, double-blind clinical trial, placebo control with FDA …

… cytokine storm (4) and no occult sepsis (negative procalcitonin). A 5-day course of remdesivir
and/or dexamethasone for up to 10 days was administered to patients with severe disease …

… The cytokine storm includes a clinically … on the cytokine storm induced by TLR ligands,
primarily through PDGFR pathways, which could be potentially used to reduce cytokine storms in …

… Considering these limitations, the presented data in patients with severe COVID-19 and
sHLH warrant larger clinical trials to validate these results and to demonstrate the usefulness of …